SG11201509798PA - Formulation comprising a hypolipidemic agent - Google Patents
Formulation comprising a hypolipidemic agentInfo
- Publication number
- SG11201509798PA SG11201509798PA SG11201509798PA SG11201509798PA SG11201509798PA SG 11201509798P A SG11201509798P A SG 11201509798PA SG 11201509798P A SG11201509798P A SG 11201509798PA SG 11201509798P A SG11201509798P A SG 11201509798PA SG 11201509798P A SG11201509798P A SG 11201509798PA
- Authority
- SG
- Singapore
- Prior art keywords
- formulation
- hypolipidemic agent
- hypolipidemic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (lv) | 2013-07-25 | 2013-07-25 | |
| PCT/IN2014/000489 WO2015011730A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201509798PA true SG11201509798PA (en) | 2016-02-26 |
Family
ID=51787141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201509798PA SG11201509798PA (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9610277B2 (lv) |
| EP (1) | EP3024446A1 (lv) |
| JP (1) | JP2016523895A (lv) |
| KR (1) | KR101786843B1 (lv) |
| CN (1) | CN105407873A (lv) |
| AP (1) | AP2015008876A0 (lv) |
| AR (1) | AR097067A1 (lv) |
| AU (1) | AU2014294548B2 (lv) |
| BR (1) | BR112015031878A2 (lv) |
| CA (1) | CA2917923A1 (lv) |
| EA (1) | EA201690072A1 (lv) |
| HK (1) | HK1219222A1 (lv) |
| IN (1) | IN2013MU02470A (lv) |
| MA (1) | MA38865A1 (lv) |
| MX (1) | MX2015016971A (lv) |
| NZ (1) | NZ714558A (lv) |
| PH (1) | PH12015502802A1 (lv) |
| SG (1) | SG11201509798PA (lv) |
| TW (1) | TW201545773A (lv) |
| WO (1) | WO2015011730A1 (lv) |
| ZA (1) | ZA201508682B (lv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007136290A1 (en) | 2006-05-23 | 2007-11-29 | Intel Corporation | Millimeter-wave communication system with directional antenna and one or more millimeter-wave reflectors |
| UA110813C2 (uk) | 2011-01-31 | 2016-02-25 | Каділа Хелткере Лімітед | Лікування ліподистрофії |
| CN105377246B (zh) | 2013-04-22 | 2018-03-20 | 卡迪拉保健有限公司 | 针对非酒精性脂肪性肝病(nafld)的新组合物 |
| WO2014195967A2 (en) | 2013-05-30 | 2014-12-11 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (lv) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
| US10385017B2 (en) | 2015-10-14 | 2019-08-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| KR101913830B1 (ko) * | 2016-12-05 | 2018-10-31 | 주식회사 코쿤디자인 | 기능성 led 어셈블리를 이용한 디스플레이 장치 |
| ES2894261T3 (es) | 2016-12-09 | 2022-02-14 | Cadila Healthcare Ltd | Tratamiento de la colangitis biliar primaria |
| US20220175721A1 (en) * | 2019-02-13 | 2022-06-09 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
| WO2020183379A1 (en) * | 2019-03-11 | 2020-09-17 | Cadila Healthcare Limited | Novel salts, crystalline forms and premix of hypolipidemic agent |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| NZ253742A (en) | 1992-07-03 | 1997-06-24 | Smithkline Beecham Plc | Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| BR9508468A (pt) | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
| TW480262B (en) | 1995-04-28 | 2002-03-21 | Daiichi Seiyaku Co | A taxol derivative having an antitumor activity and a pharmaceutical composition comprising the same |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| CN1208326C (zh) | 1998-04-23 | 2005-06-29 | 雷迪实验室有限公司 | 杂环化合物及其在医药方面的应用、其制备方法及含有它们的药物组合物 |
| CN100357281C (zh) | 1998-05-27 | 2007-12-26 | 雷迪实验室有限公司 | 双环化合物、其制备方法和包含它们的药物组合物 |
| AU6325799A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| AU6325899A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| AU6325599A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| CA2397828C (en) | 2000-01-19 | 2007-09-04 | Cadila Healthcare Ltd. | Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| AU2001286163A1 (en) | 2000-09-22 | 2002-04-02 | Dr. Reddy's Research Foundation | An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP4745616B2 (ja) * | 2003-02-26 | 2011-08-10 | 武田薬品工業株式会社 | 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法 |
| JP4261546B2 (ja) | 2003-09-26 | 2009-04-30 | 三菱レイヨン株式会社 | 電気泳動装置および電気泳動法 |
| CN102134229B (zh) | 2004-03-15 | 2020-08-04 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| CN101389333A (zh) * | 2006-02-22 | 2009-03-18 | 卫材R&D管理有限公司 | 稳定化药物组合物 |
| EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| JP5424571B2 (ja) * | 2007-04-12 | 2014-02-26 | 協和発酵キリン株式会社 | トピラマート含有固形製剤 |
| ES2681794T3 (es) | 2009-11-26 | 2018-09-17 | Genfit | Uso de derivados de 1,3-difenilprop-2-en-1-ona para tratar trastornos hepáticos |
| WO2012051333A1 (en) * | 2010-10-12 | 2012-04-19 | The Johns Hopkins University | Antitussive compositions comprising memantine |
| UA110813C2 (uk) | 2011-01-31 | 2016-02-25 | Каділа Хелткере Лімітед | Лікування ліподистрофії |
| CN105377246B (zh) * | 2013-04-22 | 2018-03-20 | 卡迪拉保健有限公司 | 针对非酒精性脂肪性肝病(nafld)的新组合物 |
| WO2014195967A2 (en) | 2013-05-30 | 2014-12-11 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (lv) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| IN2013MU02828A (lv) | 2013-08-29 | 2015-07-03 | Cadila Healthcare Ltd | |
| US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
-
2013
- 2013-07-25 IN IN2470MU2013 patent/IN2013MU02470A/en unknown
-
2014
- 2014-07-24 MA MA38865A patent/MA38865A1/fr unknown
- 2014-07-24 JP JP2016522969A patent/JP2016523895A/ja active Pending
- 2014-07-24 WO PCT/IN2014/000489 patent/WO2015011730A1/en active Application Filing
- 2014-07-24 EP EP14787059.6A patent/EP3024446A1/en not_active Withdrawn
- 2014-07-24 US US14/899,912 patent/US9610277B2/en active Active
- 2014-07-24 SG SG11201509798PA patent/SG11201509798PA/en unknown
- 2014-07-24 KR KR1020157036380A patent/KR101786843B1/ko active IP Right Grant
- 2014-07-24 BR BR112015031878A patent/BR112015031878A2/pt not_active IP Right Cessation
- 2014-07-24 TW TW103125304A patent/TW201545773A/zh unknown
- 2014-07-24 AU AU2014294548A patent/AU2014294548B2/en not_active Expired - Fee Related
- 2014-07-24 CN CN201480041453.7A patent/CN105407873A/zh active Pending
- 2014-07-24 MX MX2015016971A patent/MX2015016971A/es active IP Right Grant
- 2014-07-24 EA EA201690072A patent/EA201690072A1/ru unknown
- 2014-07-24 CA CA2917923A patent/CA2917923A1/en not_active Abandoned
- 2014-07-24 NZ NZ714558A patent/NZ714558A/en not_active IP Right Cessation
- 2014-07-25 AR ARP140102777A patent/AR097067A1/es unknown
-
2015
- 2015-07-24 AP AP2015008876A patent/AP2015008876A0/xx unknown
- 2015-11-25 ZA ZA2015/08682A patent/ZA201508682B/en unknown
- 2015-12-17 PH PH12015502802A patent/PH12015502802A1/en unknown
-
2016
- 2016-06-21 HK HK16107193.2A patent/HK1219222A1/zh unknown
-
2017
- 2017-03-31 US US15/475,812 patent/US10098868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PH12015502802A1 (en) | 2016-03-14 |
| EP3024446A1 (en) | 2016-06-01 |
| EA201690072A1 (ru) | 2016-06-30 |
| NZ714558A (en) | 2017-02-24 |
| US20160136131A1 (en) | 2016-05-19 |
| MX2015016971A (es) | 2016-04-25 |
| JP2016523895A (ja) | 2016-08-12 |
| KR20160013150A (ko) | 2016-02-03 |
| WO2015011730A1 (en) | 2015-01-29 |
| HK1219222A1 (zh) | 2017-03-31 |
| AP2015008876A0 (en) | 2015-11-30 |
| AU2014294548A1 (en) | 2015-12-17 |
| AU2014294548B2 (en) | 2017-08-10 |
| AR097067A1 (es) | 2016-02-17 |
| US9610277B2 (en) | 2017-04-04 |
| CN105407873A (zh) | 2016-03-16 |
| TW201545773A (zh) | 2015-12-16 |
| BR112015031878A2 (pt) | 2017-07-25 |
| US10098868B2 (en) | 2018-10-16 |
| ZA201508682B (en) | 2017-03-29 |
| IN2013MU02470A (lv) | 2015-06-26 |
| KR101786843B1 (ko) | 2017-10-18 |
| CA2917923A1 (en) | 2015-01-29 |
| MA38865A1 (fr) | 2017-12-29 |
| US20170266158A1 (en) | 2017-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219222A1 (zh) | 包含降血脂藥的製劑 | |
| EP2956781A4 (en) | RECHARGE BLOCK | |
| GB201304784D0 (en) | Dispenser | |
| EP2968569A4 (en) | COUGAR FORMULATION | |
| GB201317990D0 (en) | A conncetor | |
| GB2510428B (en) | Glove dispenser | |
| GB201320432D0 (en) | Novel formulation | |
| EP2992813A4 (en) | LIQUID DETECTION INSTRUMENT | |
| GB2515360B (en) | Dispenser | |
| EP2952799A4 (en) | PIPE REINFORCING ELEMENT | |
| SI3060256T1 (sl) | Nova stabilna formulacija | |
| GB201322948D0 (en) | Improved formulation | |
| EP2958828A4 (de) | Spender | |
| SG11201604752SA (en) | Antibacterial peptide-inducing agent | |
| ZA201505008B (en) | Cleaning agent | |
| HUE060750T2 (hu) | Fluorozó-szerek | |
| GB2517232B (en) | Formulation | |
| GB201317718D0 (en) | Novel formulation | |
| TWI563390B (en) | Completion packet return | |
| EP3037100A4 (en) | MEANS TO PREVENT MUSCLE ATROPHY | |
| HK1209981A1 (en) | Formulation | |
| GB201312347D0 (en) | Formulation | |
| GB201312761D0 (en) | A composition | |
| GB201313018D0 (en) | A Composition for anti-microbial use | |
| GB201306657D0 (en) | Trestle |